Market Overview

Elan Announces Publication of EGM Circular Discussing Proposed Demerger of Neotope Business


Elan Corporation (NYSE: ELN) today announced the publication and
filing of a circular to shareholders convening an extraordinary general
meeting (“EGM”) to be held in the Davenport Hotel, 8/10 Merrion Street
Lower, Dublin 2, Ireland at 10.00 a.m. on Wednesday, December 12, 2012
at which a resolution in connection with the proposed demerger of Elan's
Neotope business (now referred to as the Prothena Business), originally
announced on August 13, 2012, will be considered and voted on.

As previously announced, and assuming the necessary preconditions are
fulfilled, including an affirmative vote of the Elan shareholders at the
EGM, the Prothena business which comprises a substantial portion of
Elan's drug discovery business platform, will be separated into another

See full press release

Posted-In: News Guidance Contracts Management Global


Related Articles (ELN)

View Comments and Join the Discussion!

Partner Center